Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Other Non-Current Assets (2018 - 2025)

Historic Other Non-Current Assets for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to $13.7 million.

  • Bicycle Therapeutics' Other Non-Current Assets rose 3794.77% to $13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year increase of 3794.77%. This contributed to the annual value of $11.1 million for FY2024, which is 9119.48% up from last year.
  • Bicycle Therapeutics' Other Non-Current Assets amounted to $13.7 million in Q3 2025, which was up 3794.77% from $13.8 million recorded in Q2 2025.
  • Bicycle Therapeutics' 5-year Other Non-Current Assets high stood at $13.8 million for Q2 2025, and its period low was $2.2 million during Q1 2021.
  • For the 5-year period, Bicycle Therapeutics' Other Non-Current Assets averaged around $7.5 million, with its median value being $6.4 million (2024).
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first soared by 15169.13% in 2023, then tumbled by 4583.4% in 2024.
  • Over the past 5 years, Bicycle Therapeutics' Other Non-Current Assets (Quarter) stood at $3.4 million in 2021, then soared by 145.3% to $8.5 million in 2022, then plummeted by 31.52% to $5.8 million in 2023, then skyrocketed by 91.19% to $11.1 million in 2024, then grew by 23.82% to $13.7 million in 2025.
  • Its Other Non-Current Assets was $13.7 million in Q3 2025, compared to $13.8 million in Q2 2025 and $12.4 million in Q1 2025.